286 reports of this reaction
1.1% of all DOCOSANOL reports
#16 most reported adverse reaction
SWELLING FACE is the #16 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 286 FDA adverse event reports linking DOCOSANOL to SWELLING FACE. This represents approximately 1.1% of all 26,055 adverse event reports for this drug.
Patients taking DOCOSANOL who experience swelling face should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SWELLING FACE is a less commonly reported adverse event for DOCOSANOL, but still significant enough to appear in the safety profile.
In addition to swelling face, the following adverse reactions have been reported for DOCOSANOL:
The following drugs have also been linked to swelling face in FDA adverse event reports:
SWELLING FACE has been reported as an adverse event in 286 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
SWELLING FACE accounts for approximately 1.1% of all adverse event reports for DOCOSANOL, making it a notable side effect.
If you experience swelling face while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.